Transthyretin-directed RNA Interaction [EPC] - N0000193849

Pharmacologic Class Information

Pharmacologic Code N0000193849
Pharmacologic Name Transthyretin-directed RNA Interaction
Pharmacologic Uses
  • transthyretin-directed antisense oligonucleotide
  • transthyretin-directed small interfering RNA
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Transthyretin-directed RNA Interaction

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Transthyretin-directed RNA Interaction [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71336-1000Onpattro Non-Proprietary Name: PatisiranInjection, Lipid ComplexIntravenousAlnylam Pharmaceuticals, Inc.ACTIVE
71336-1003Amvuttra Non-Proprietary Name: VutrisiranInjectionSubcutaneousAlnylam Pharmaceuticals, Inc.ACTIVE
72126-007Tegsedi Non-Proprietary Name: InotersenInjection, SolutionSubcutaneousAkcea Therapeutics, Inc.ACTIVE